Form 4: McKesson Corp CEO Brian Tyler Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
McKesson's CEO, Brian Tyler, exercised stock options and sold shares on March 15, 2024, according to a pre-arranged trading plan.
Summary
- Brian S. Tyler, CEO of McKesson Corp, executed a transaction involving company stock on March 15, 2024.
- Tyler exercised an employee stock option to acquire 3,473 shares at a price of $159.
- Simultaneously, Tyler sold 3,473 shares at $524.55 per share.
- These transactions were conducted under a pre-arranged Rule 10b5-1(c) trading plan established on December 2, 2022.
- Following these transactions, Tyler directly owns 43,445 shares of McKesson common stock.
- Tyler also indirectly owns 214.0939 shares through the McKesson Corporation 401(k) Retirement Savings Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing simply reports stock transactions under a pre-existing plan. There's no indication of positive or negative implications for the company.
Positives
- The transactions were pre-planned under a Rule 10b5-1(c) trading arrangement, suggesting they were not based on insider information.
Industry Context
Executive stock transactions are common and closely monitored, especially in large publicly traded companies like McKesson. Rule 10b5-1 plans are frequently used to allow insiders to trade without concerns about insider trading violations.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to manage their stock holdings and avoid accusations of insider trading.
- Comparing Brian Tyler's compensation and stock ownership to those of CEOs at similar companies like Cardinal Health (CAH) and AmerisourceBergen (ABC) could provide further context.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders, but the pre-planned nature of the transaction mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 2018-05-23 | 25% of employee stock option vested |
| 2019-05-23 | 25% of employee stock option vested |
| 2020-05-23 | 25% of employee stock option vested |
| 2021-05-23 | 25% of employee stock option vested |
| 2022-12-02 | Date of Rule 10b5-1(c) trading arrangement |
| 2024-03-15 | Transaction date: Exercise of stock options and sale of shares |
| 2024-05-23 | Employee Stock Option Expiration Date |
| 2024-03-18 | Date of signature for the SEC filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.